P
Palleon Pharmaceuticals
Leading biotechnology company
About Palleon Pharmaceuticals
Palleon Pharmaceuticals is a biotechnology company focused on developing novel cancer therapies by targeting the Siglec Sialoglycan axis, a pathway that plays a critical role in immune suppression in tumors. The company operates in the oncology market, primarily serving patients with various forms of cancer. Palleon's business model revolves around the research and development of first-in-class medicines that aim to transform cancer treatment. Revenue is generated through partnerships, licensing agreements, and potentially future sales of approved therapies. The company's core technologies include the EAGLE and HYDRA platforms, which are designed to investigate and block tumor immunosuppressive glyco codes, thereby enhancing anticancer immunity. Palleon Pharmaceuticals is committed to advancing innovative treatments that can significantly improve patient outcomes.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Palleon Pharmaceuticals is 5K monthly website visits, up 56.3% over the last three months. Palleon Pharmaceuticals's team declined 12% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Palleon Pharmaceuticals in the Waltham ecosystem
The Palleon Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
SR One
Abbvie Biotech Ventures
Takeda Ventures
Citadel
Matrix Capital Management- PVPfizer Ventures
Vertex Ventures HC
Other known investors2 additional known investors
King's College London
Stanford University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Palleon Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Palleon Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









